Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Press Releases
Biosimilars Council Press Releases
Press Releases
Press Releases
August 15, 2024
AAM
Benefit Projected by CMS Price Setting Cannot Compare to Benefit of Generic and Biosimilar Medicines
Press Releases
July 9, 2024
AAM
FTC Report Critical of PBMs Highlights Middlemen Profits Over Patient Savings
Press Releases
June 26, 2024
AAM
Blog: Bill Addressing Drug Shortages Provides Long Overdue Relief from Penalties Hurting Generic Drug Market
Press Releases
May 30, 2024
AAM
AAM Submits Comments to HHS and FTC on the Impact of GPOs and Wholesalers on Access to Generic Medicines
Press Releases
May 21, 2024
AAM
AAM Applauds Senate Judiciary Committee Efforts to Protect Patients and Skinny Labeling
Press Releases
April 24, 2024
AAM
Seniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why?
Press Releases
February 20, 2024
AAM
Medicare Plans Increase Patient Costs for Generic Medicines
Press Releases
February 14, 2024
AAM
AAM Commends HHS and FTC Call for Information and Solutions on Drug Shortages and Patient Access to Generics and Biosimilars
Press Releases
February 6, 2024
AAM
AAM White Paper: Hatch-Waxman Turns 40
Press Releases
January 23, 2024
AAM
AAM Requests Federal Injunction to Block Illinois’ Unconstitutional Drug Price Law
Press Releases
January 23, 2024
AAM
Keren Haruvi Named Chair of the Association for Accessible Medicines Board of Directors
Press Releases
December 8, 2023
AAM
Keren Haruvi Announced as Chair of the Association for Accessible Medicines Board of Directors
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH